Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: MarcG who wrote (37)	11/12/1997 12:44:00 PM
From: Graham Marshman	Respond to of 857

Marc, True. I do believe HEB will generally move upwards in any fairly decent market, though. However, you're right, news is the big kicker. Graham

To: MarcG who wrote (37)	11/12/1997 4:12:00 PM
From: Graham Marshman	Read Replies (1) \| Respond to of 857

Ooh! That feels better. Like finally peeing after a 3-hour movie. I knew this visit to low 7400s was in their waiting somewhere. Now it's out of the way and we can get back to business. Graham

To: MarcG who wrote (37)	11/12/1997 11:09:00 PM
From: Gerald Underwood	Read Replies (1) \| Respond to of 857

Marc, Interesting bit of news turned up in HEB 10Q just released for qtr ending 9/30. Under recent developments, it seems that HEB made two private placements of ttl 4,840,000 shrs for $10,005.000. in October 97. Ever wonder what happened to the stock price during October? However, in spite of this dilution, stock price still shows remarkable strength even during general market paranoia and company selling off stock for half price. Biotechs are taking some hits. Regards, Gerry